| lamivudine / Generic mfg. |
NCT00146705: Long Term Follow-up of Pegylated-Interferon Alpha-2b |
|
|
| Completed | N/A | 266 | Europe | blood samples are taken once | Foundation for Liver Research | Chronic Hepatitis B | | 09/06 | | |
NCT00059267: Prevention of Recurrent Hepatitis B After Liver Transplantation |
|
|
| Completed | N/A | 317 | US | HBIG, Epivir, Hepsera | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan | Hepatitis B, Cirrhosis, Acute Liver Failure, Hepatocellular Carcinoma | 11/07 | 11/07 | | |
NCT00516945: A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers |
|
|
| Completed | N/A | 110 | RoW | Lamivudine | Hospital Authority, Hong Kong | Hepatitis B, Neoplasms | | 06/08 | | |
NCT01376154: Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) |
|
|
| Completed | N/A | 342 | NA | Lamivudine | GlaxoSmithKline | Hepatitis B, Chronic | 12/09 | 02/11 | | |
NCT01013272: Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load |
|
|
| Completed | N/A | 50 | RoW | Entecavir, Baraclude, Lamivudine, Zeffix | The University of Hong Kong | Hepatitis B, Chronic | 07/10 | 07/10 | | |
| Completed | N/A | 1 | RoW | No intervention | ViiV Healthcare, GlaxoSmithKline | Hepatitis B, Chronic | 06/11 | 06/11 | | |
NCT01705704: A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B |
|
|
| Completed | N/A | 269 | Europe, RoW | | Hoffmann-La Roche | Hepatitis B, Chronic | 02/13 | 02/13 | | |
